We recently released our inaugural PitchBook-NVCA Venture Monitor as a comprehensive resource on all matters venture capital. You can download the full 20-page report for free, but if you’d like to fast forward to the highlights, we’ve collated the top charts below:
Superbugs are causing a super problem in health care, but combating these drug-resistant bacteria presents quite a challenge. Many antibiotic prescriptions administered in the U.S. are either unnecessary or inappropriate and can lead to antibiotic-resistant infections or other adverse events. In an effort to improve antibiotic use, the Agency for Healthcare Research and Quality within the U.S. Department of Health and Human Services has awarded the Johns Hopkins Armstrong Institute for Patient Safety and Quality a $16 million contract, which will be spread over a period of five years — two initial years, plus three optional years. The Armstrong Institute will collaborate with the Chicago-based research institute NORC to identify which approaches are most helpful and to operationalize efforts to optimize antibiotic prescribing.
Two University of Maryland, Baltimore (UMB) researchers and a UM Venture startup company stemming from the University’s tech transfer efforts received financial awards to accelerate the commercial development of their biomedical inventions into treatments and devices to meet today’s health challenges.
For the last eight years, the UMB Commercial Advisory Board and the Johns Hopkins Alliance for Science and Technology have held a yearly meeting of faculty of both universities, advisors and potential investors to explore pathways to commercializing inventions created in the universities’ laboratories, and encourage entrepreneurship among faculty members. This year, $200,000 was awarded to faculty and startup companies from both universities. UMB inventors competed for a UM Ventures Award and one of two Abell Foundation Awards. UM Venture start-ups presented their companies for the chance to win a UM Venture Start-up Award. This year’s UMB-affiliated awards went to:
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Amitiza (lubiprostone; Sucampo and Takeda) for the addition of two adverse reactions: syncope and hypotension.
Cases of syncope and hypotension have been reported with Amitiza in the postmarketing setting. Most cases have occurred in patients taking 24mcg twice daily and some occurred within an hour after taking the first dose or subsequent doses. The new label addition states that syncope and hypotension generally resolved following Amitiza discontinuation or prior to next dose, but recurrence has been reported with subsequent doses. Several cases reported concomitant use of medications known to lower blood pressure, which may increase the risk for the development of syncope or hypotension. Clinicians are advised to make patients aware of the risk; side effects such as diarrhea and vomiting may increase the risk for syncope and hypotension.
As cybersecurity becomes more of an imperative for individuals and organizations, several regions in the US are investing money and efforts in security innovation.
Silicon Valley may be the most famous hotspot for tech innovation in the country, but it’s far from the only place driving cybersecurity advancement. Areas such as the Washington, DC region and the Boston metro area are home to a growing number of security startups and incubators.
THE 7TH GALIEN FORUM EVENT: The 2016 Galien Forum will take place on the morning of October 27th, 2016, and will feature round table debates focusing on critical global healthcare issues and challenges. Our annual life science Forum is rapidly becoming a leading event for discussing issues of innovation in the industry. The Galien Forum brings together leading CEOs, biomedical experts from industry, academia and government.
Your search ends at the Universities at Shady Grove (USG), where nine top Maryland universities bring 40 of their best degree programs to YOU on one convenient campus in Rockville. Take your classes at USG, and earn your bachelor’s degree from the university offering your major.
Your search ends at the Universities at Shady Grove (USG), where nine top Maryland universities bring 40 of their best degree programs to YOU on one convenient campus in Rockville. Take your classes at USG, and earn your bachelor’s degree from the university offering your major.
Chief Commercial and Strategy Officer, On Demand Pharmaceuticals / BHI EIR
Jarrod Borkat is a 15-year veteran in the biopharmaceutical industry and currently the Chief Commercial and Strategy Officer with On Demand Pharmaceuticals. He joined MedImmune in 2010, and served as Senior Director/Head, Global External Partnerships & Collaborations. In this role he was responsible for establishing and overseeing global strategic collaborations with universities, non-profit organizations and government entities, across all the therapeutic areas relevant to MedImmune. His team led the creation of several multi-million dollar collaborations, including one with Johns Hopkins University and one with University of Maryland. Prior to this role, Jarrod led the Portfolio Strategy & Management function for MedImmune, helping the organization optimize its R&D portfolio. Before joining MedImmune, Jarrod worked at Boehringer Ingelheim (BI) Pharmaceuticals, Inc. for 11 years, rising through the ranks in the sales and commercial organization. During his time at BI, he spent two years in Germany, working at their corporate headquarters, leading the global commercial strategy for their CNS franchise. His last position prior to leaving BI was Director of U.S. Marketing, HIV. Jarrod has won multiple awards throughout his career, including being recognized as an industry “Top 25 Direct-to-Consumer Marketer of the Year” in 2007. He is also active in several industry organizations and has served on industry-related panels. In addition to his professional accomplishments, Jarrod serves on the Kentlands Board of Trustees and the Kentlands Community Foundation Board. He also ran a marathon on all 7 continents with his father, making them the first father/son duo to have accomplished this challenging endeavor. Jarrod earned an M.B.A. from Kennesaw State University, with concentrations in finance and marketing, and earned a B.S. in Biology from the University of Georgia.
Marriott International Inc. has selected downtown Bethesda as the site of its new headquarters. Exactly where is still to be determined.
The hospitality giant (NASDAQ: MAR), now the largest in the world following its merger with Starwood Hotels & Resorts Worldwide Inc., says it is still considering several Metro-accessible sites for a $600 million facility. It expects to make that selection in the first half of 2017.
